Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Daily

Download Data

Alpha Tau Medical Ltd Enterprise Value (EV) on June 03, 2024: USD 109.46 M

Alpha Tau Medical Ltd Enterprise Value (EV) is USD 109.46 M on June 03, 2024, a NA change year over year. Enterprise Value is a measure of a company's total value, including both its equity and debt. It represents the theoretical takeover price of a company and is often used in valuation methods. Enterprise value is calculated as the sum of a company's market capitalization, total debt, and subtracting its cash and short-term investments.

Alpha Tau Medical Ltd 52-week high Enterprise Value (EV) is USD 133.53 M on March 20, 2024, which is 21.99% above the current Enterprise Value (EV).
Alpha Tau Medical Ltd 52-week low Enterprise Value (EV) is USD 85.46 M on May 02, 2024, which is -21.93% below the current Enterprise Value (EV).
Alpha Tau Medical Ltd average Enterprise Value (EV) for the last 52 weeks is USD 111.64 M.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends